Tempest Therapeutics, Inc.TPSTNASDAQ
Loading
Enterprise value to EBITDA ratio
Percentile
P46
Within normal range
vs 3Y Ago
-14.3x
Contraction
Streak
1 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2024 | -7.17 | +77.0% |
| 2023 | -31.21 | -24998.4% |
| 2022 | -0.12 | -124.9% |
| 2021 | 0.50 | +173.8% |
| 2020 | 0.18 | +100.7% |
| 2019 | -26.24 | -713.6% |
| 2018 | -3.23 | -2778.2% |
| 2017 | 0.12 | +101.6% |
| 2016 | -7.46 | +84.2% |
| 2015 | -47.24 | - |